Inside the MSO
For the better part of a decade, healthcare consolidation was fueled by a specific economic condition: cheap capital.
When borrowing costs are low, platforms can afford more inefficiency and growth covers a lot of operational mistakes. If a platform overpays for a practice or carries bloated overhead, cheap debt provides a margin of error.
When interest rates rise, that margin shrinks. In a high-rate environment, operational pressure increases and governance and lane clarity get stress-tested.
This is math. When the cost of servicing debt increases materially, the cash available for operations decreases. This applies to any leveraged structure, regardless of who the equity sponsor is. For physicians inside a platform, or those considering joining one, macroeconomic shifts are not abstract. They eventually show up as operational pressure.
The Mechanism of Stress
Most platforms use leverage, which is common, but the structure of that debt matters.
If a platform was built on floating-rate debt during a low-rate period, a rise in rates increases monthly debt service. If operating cash flow is not strong enough to absorb that increase, management has to find cash elsewhere. When financial pressure increases, platforms do not get many choices. They look for cash.
Refinancing Does Not Remove Pressure, It Changes It
When traditional bank debt becomes expensive or restrictive, platforms refinance. Sometimes that refinance comes from private credit, non-bank lenders, or minority capital rather than traditional banks.
The terms change, but the underlying math does not. Private credit often carries higher interest costs, tighter cash flow expectations, or more frequent performance testing. Minority capital may avoid near-term amortization but introduce new return targets, reporting requirements, or governance influence.
From the clinic's perspective, the distinction matters less than the result. Regardless of the capital source, the organization still has to produce cash. If that cash is not generated organically, pressure shifts downstream into staffing decisions, output expectations, capital spending, and operational tolerance.
Different capital structures change how pressure shows up, not whether it shows up. For physicians, the key question is not whether they refinanced. It is what behaviors the new capital structure requires to stay stable.
What Changes First
When financial pressure moves from a spreadsheet to the clinic floor, it usually follows a predictable path. Four areas tend to shift first when capital gets expensive.
The first is staffing levels. Labor is often the largest expense in a medical practice. When pressure hits, hiring slows, open roles stay open, overtime is reduced, and experienced staff are replaced with lower-cost hires. The downstream impact is that teams get stretched, burnout rises, patient wait times increase, and rooms turn slower.
The second is capital expenditure delays. In stable operations, equipment is replaced on a planned schedule. Under pressure, upgrades get delayed. Equipment refreshes, IT upgrades, and facility improvements get pushed from this quarter to next year. The practice starts to look and feel tired, and physicians are asked to work around aging systems.
The third is output pressure. If costs cannot be cut enough, volume becomes the next lever. There is a sudden focus on provider capacity, shorter slots, more double-booking, and more clinic days. Days feel more compressed and operational pressure begins to collide with clinical pacing.
The fourth is vendor standardization. Under stress, platforms often standardize and renegotiate suppliers. Mandates come down to switch to cheaper vendors or alternative supplies. Friction increases, preferred tools change, and even if quality holds, the team feels the strain.
Questions Physicians Can Ask
If you are evaluating a partner in a high-rate environment, you do not need to be a finance expert to ask a few structural questions.
The first is whether the platform is generating cash after debt service. EBITDA is not the same thing as cash after paying lenders. If the platform is not generating cash after debt service, it may rely on new capital injections to stay stable.
The second is what the philosophy on capital expenditure and maintenance looks like. Ask how capital spending was handled over the last twelve months and what is planned for the next twelve. If maintenance is being deferred while the platform grows, pressure is likely building.
The third is how debt is structured. Is it fixed or floating? When does it mature? Platforms facing a refinance at higher rates will be under more pressure to cut and compress.
The fourth is whether staffing has changed in the last year. Ask about turnover, open positions, and whether responsibilities have shifted. Optimizing labor can mean many things.
The fifth is what the plan for growth looks like. Is growth driven primarily by more acquisitions requiring more expensive capital, or by improving operations inside existing practices? In high-rate environments, operational growth tends to be more durable than acquisition-fueled growth.
Stability Is an Asset
In a low-rate environment, the highest bidder often wins. In a high-rate environment, the best operator often wins.
When capital is expensive, durable platforms tend to have disciplined governance, realistic margins, and a focus on operational execution. For physicians, the goal is to partner with a structure built to stay stable through the market.
How Verdira Approaches This
Clinical decisions remain with physicians. MSO scope is clearly defined in writing and tied to real services. Governance is clarified before signing so expectations remain stable after close. We build long-duration platforms and don't operate on forced exits.
If you are evaluating an MSO partnership or successor role and want to sanity-check structure and expectations, we are open to thoughtful conversations.
This article is for general educational purposes and is not legal advice.
Verdira is a healthcare acquisition platform focused on ophthalmology practices. Physician ownership. Transparent structure. No volume quotas. If you're looking for a different model, or you know a colleague who is, contact us today.
Contact info@verdira.com 307-381-3734 verdira.com

Written by
Verdira Team
Verdira is building a permanent home for ophthalmology practices. We write about succession, physician ownership, and the forces reshaping eye care in the United States.
Ready to secure your legacy?
Let's Talk
We're here to ensure your hard work is valued and your business thrives as part of Verdira.